APC, the Irish pharmaceutical R&D company, to unveil significant investment to facilitate the development and manufacture of Covid Vaccines and Advanced Therapeutics

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

An Taoiseach Michael Martin will be in attendance

10am on Thursday 10th June 2021

APC Ltd, the award-winning Irish pharmaceutical research and development company, will announce a significant expansion of the business on Thursday 10 June.

The investment, which is supported by Enterprise Ireland, will enable the rapid research and manufacture of vaccines, including Covid 19 vaccines, and other advanced therapeutics for rare diseases. It will provide supply chains nationally and across Europe with these vital medicines, positioning Ireland as a significant contributor on the international stage to the manufacture of Covid Vaccines and other critical Advanced Therapeutics.

Attending will be:

  • An Taoiseach, Michael Martin
  • APC CEO, Dr. Mark Barrett
  • Enterprise Ireland CEO Leo Clancy

*Please note that An Taoiseach will be available for photography while Mark Barrett and Leo Clancy will be available for interview about the APC announcement

Where:             Building 11, Cherrywood Business Park, Loughlinstown, Co. Dublin, D18 DH50

When:              Thursday 10th June 2021

Time:               10am

*NB*                 Please confirm attendance via email or phone to the below contacts as numbers will be

limited due to Covid-19 restrictions

RSVP:              Breda Brown / Viv Murphy – Unique Media

                        Tel: (01) 5225200 / 087 2487120 (BB)

END

This website uses cookies in order to improve the site and user experience. By continuing to use it, you agree to our Privacy Policy.